Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)

COVID-19 vaccination in patients with cancer (with Narjust Duma)

We speak to medical oncologist Narjust Duma, from the University of Wisconsin in the USA, about COVID-19 vaccination in people with cancer, discussing issues such as vaccine timing, side-effects, and key unanswered research questions.

Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman)

In this Medicine Matters oncology podcast, we speak to Gary Lyman (Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, USA) about the impact of the COVID-19 outbreak on the conduct of cancer clinical trials.

Find more on Medicine Matters oncology

The UK Coronavirus Cancer Monitoring Project: What you need to know (with Lennard Lee)

Co-project leader Lennard Lee talks about the inception and development of the initiative that will provide insight into the impact of COVID-19 on people with cancer and facilitate shared learning that will benefit patient care.

Find more on Medicine Matters oncology

CCC19: Introducing The COVID-19 and Cancer Consortium (with Gilberto Lopes)

Gilberto Lopes (Sylvester Comprehensive Cancer Center at the University of Miami, Florida, USA), a steering committee member of CCC19, tells us about the registry collating data on cancer patients with comorbid COVID-19 to provide an evidence base for future decision-making.

Find more on Medicine Matters oncology

Image credit: © koto_feja/Getty Images/iStock

COVID-19 and cancer: Changing practices to meet patient needs (with Beth Sandy)

Thoracic oncology nurse practitioner Beth Sandy explains how the coronavirus pandemic is affecting cancer patient care and how strategies such as telemedicine are coming into their own.

Find more on Medicine Matters oncology

Image credit: Coronavirus illustration © dottedyeti/stock.adobe.com